INCY

$0.00

(

+0.00%

)
Quote details

stock

Incyte Corporation

NASDAQ | INCY

105.70

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 5, 2025)

$20.21B

Market Cap

17.44

P/E Ratio

5.9

EPS

$106.47

52 Week High

$53.56

52 Week Low

HEALTHCARE

Sector

INCY Chart

Recent Chart
Price Action

INCY Technicals

Tags:

INCY Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $3.9B
Total Revenue $4.2B
Cost Of Revenue $378M
Costof Goods And Services Sold $378M
Operating Income $80M
Selling General And Administrative $1.2B
Research And Development $2.6B
Operating Expenses $3.8B
Investment Income Net -
Net Interest Income $126M
Interest Income $129M
Interest Expense $2.3M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $89M
Income Before Tax $317M
Income Tax Expense $284M
Interest And Debt Expense -
Net Income From Continuing Operations $33M
Comprehensive Income Net Of Tax -
Ebit $319M
Ebitda $408M
Net Income $33M

Revenue & Profitability

Earnings Performance

INCY Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $5.4B
Total Current Assets $3.2B
Cash And Cash Equivalents At Carrying Value $1.7B
Cash And Short Term Investments $1.7B
Inventory $59M
Current Net Receivables $853M
Total Non Current Assets $2.2B
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $114M
Intangible Assets Excluding Goodwill $114M
Goodwill $156M
Investments -
Long Term Investments $19M
Short Term Investments $470M
Other Current Assets $169M
Other Non Current Assets -
Total Liabilities $2B
Total Current Liabilities $1.6B
Current Accounts Payable $197M
Deferred Revenue -
Current Debt -
Short Term Debt $10M
Total Non Current Liabilities $355M
Capital Lease Obligations $44M
Long Term Debt $34M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $38M
Other Current Liabilities $1.4B
Other Non Current Liabilities $321M
Total Shareholder Equity $3.4B
Treasury Stock -
Retained Earnings -$1.1B
Common Stock $193K
Common Stock Shares Outstanding $211M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $335M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $89M
Capital Expenditures $86M
Change In Receivables -
Change In Inventory -$128M
Profit Loss -
Cashflow From Investment $158M
Cashflow From Financing -$2B
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$2B
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $33M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $3.9B
Total Revenue $4.2B
Cost Of Revenue $378M
Costof Goods And Services Sold $378M
Operating Income $80M
Selling General And Administrative $1.2B
Research And Development $2.6B
Operating Expenses $3.8B
Investment Income Net -
Net Interest Income $126M
Interest Income $129M
Interest Expense $2.3M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $89M
Income Before Tax $317M
Income Tax Expense $284M
Interest And Debt Expense -
Net Income From Continuing Operations $33M
Comprehensive Income Net Of Tax -
Ebit $319M
Ebitda $408M
Net Income $33M

INCY News

INCY Profile

Incyte Corporation Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Incyte Corporation, based in Wilmington, Delaware, is a leading biopharmaceutical firm specializing in the development of innovative therapies for oncology and other critical diseases. Founded in 1991, the company has established a strong commercial presence with its flagship product, Jakafi, which is used to treat myelofibrosis and polycythemia vera, while also advancing a diverse pipeline of candidates targeting various cancer types. Incyte's dedication to precision medicine and its collaborative approach to research underscore its pivotal role in addressing unmet medical needs in the healthcare landscape. With a focus on scientific innovation, Incyte aims to enhance patient outcomes and solidify its status as a key player in biopharma.

CHR
-45.58%
$0.07
NVVE
-8.57%
$0.19
MTC
+626.97%
$2.21
ASST
+16.80%
$1.46
RIVN
+23.36%
$15.42
LNAI
+40.28%
$1.17
NVDA
-1.75%
$195.21
GPUS
+11.61%
$0.39
PFE
+1.27%
$24.61
RUBI
-49.75%
$0.30
VHAI
0.00%
$0.00
BYND
-4.51%
$1.27
PLUG
+4.76%
$2.64
SNAP
-2.27%
$7.30
TSLA
+4.00%
$462.07
GRAB
-2.50%
$5.64
YDKG
-5.55%
$0.05
SLDP
+51.55%
$8.51
F
+2.50%
$13.11
SMX
+43.53%
$2.11
PLTR
-1.48%
$187.90
PINS
-21.75%
$25.75
INTC
+3.64%
$38.38
DNN
-2.55%
$2.67
AXDX
-61.36%
$0.03
AMD
+2.51%
$256.33
ACHR
+0.10%
$9.57
T
+0.49%
$24.56
AAL
+6.08%
$13.42
SMCI
-11.32%
$42.03
BITF
+5.72%
$4.05
KVUE
+1.62%
$16.23
ONDS
+0.67%
$6.00
WTO
-0.20%
$0.04
CIFR
+9.77%
$24.71
SOFI
+2.38%
$30.07
RXRX
-0.80%
$4.96
TEVA
+20.23%
$24.60
BAC
-2.03%
$52.45
NFE
+10.37%
$1.49
ETHD
-14.82%
$4.48
ADAP
-15.14%
$0.05
AMCR
+2.54%
$8.07
DVLT
-10.11%
$1.60
BTG
+0.75%
$4.03
WBD
+0.70%
$22.76
IREN
+14.67%
$76.41
MARA
+3.06%
$17.13
VALE
+3.09%
$12.31
QS
+10.55%
$17.07
AAPL
+0.03%
$270.14
RIG
0.00%
$3.90
CAN
+16.21%
$1.29
U
+18.09%
$42.36
RGTI
+5.99%
$37.29
RMBL
+60.50%
$3.21
WULF
+2.33%
$15.36
FUBO
+10.86%
$4.08
AMZN
+0.35%
$250.20
ADD
-25.47%
$0.05
BURU
+0.20%
$0.29
NVO
+0.43%
$48.46
EPWK
-6.41%
$0.07
TLRY
+3.22%
$1.28
HIMS
+2.19%
$43.73
BTBT
+3.14%
$3.28
SRM
+53.27%
$10.30
NIO
+1.81%
$7.29
PCG
+0.68%
$16.27
BMNR
+4.96%
$41.42
NCLH
-0.95%
$18.61
ZDAI
+13.94%
$0.52
RIOT
-1.58%
$18.97
JOBY
+1.62%
$15.00
NOK
+0.58%
$6.85
HTZ
-0.81%
$6.67
APPS
+23.14%
$7.29
CMG
+0.72%
$31.97
ALIT
-7.03%
$2.50
QBTS
+4.30%
$31.02
NGD
+2.40%
$6.80
GOOGL
+2.43%
$284.31
HOOD
+4.15%
$142.47
BBD
+3.62%
$3.53
BW
+28.34%
$4.80
NVTS
-5.73%
$9.86
WLGS
-5.57%
$0.04
MU
+8.93%
$237.50
IONZ
-7.60%
$4.13
SOUN
+3.89%
$15.72
HPE
+0.63%
$23.71
AG
-7.69%
$10.67
RDHL
+2.77%
$1.11
PLTZ
+2.80%
$6.24
GGB
+5.26%
$3.60
ETWO
0.00%
$3.30
HBAN
+0.13%
$15.29
CPNG
-5.94%
$30.22
PBR
+2.62%
$12.14
ABEV
+1.25%
$2.42
CHR
-45.58%
$0.07
NVVE
-8.57%
$0.19
MTC
+626.97%
$2.21
ASST
+16.80%
$1.46
RIVN
+23.36%
$15.42
LNAI
+40.28%
$1.17
NVDA
-1.75%
$195.21
GPUS
+11.61%
$0.39
PFE
+1.27%
$24.61
RUBI
-49.75%
$0.30
VHAI
0.00%
$0.00
BYND
-4.51%
$1.27
PLUG
+4.76%
$2.64
SNAP
-2.27%
$7.30
TSLA
+4.00%
$462.07
GRAB
-2.50%
$5.64
YDKG
-5.55%
$0.05
SLDP
+51.55%
$8.51
F
+2.50%
$13.11
SMX
+43.53%
$2.11
PLTR
-1.48%
$187.90
PINS
-21.75%
$25.75
INTC
+3.64%
$38.38
DNN
-2.55%
$2.67
AXDX
-61.36%
$0.03
AMD
+2.51%
$256.33
ACHR
+0.10%
$9.57
T
+0.49%
$24.56
AAL
+6.08%
$13.42
SMCI
-11.32%
$42.03
BITF
+5.72%
$4.05
KVUE
+1.62%
$16.23
ONDS
+0.67%
$6.00
WTO
-0.20%
$0.04
CIFR
+9.77%
$24.71
SOFI
+2.38%
$30.07
RXRX
-0.80%
$4.96
TEVA
+20.23%
$24.60
BAC
-2.03%
$52.45
NFE
+10.37%
$1.49
ETHD
-14.82%
$4.48
ADAP
-15.14%
$0.05
AMCR
+2.54%
$8.07
DVLT
-10.11%
$1.60
BTG
+0.75%
$4.03
WBD
+0.70%
$22.76
IREN
+14.67%
$76.41
MARA
+3.06%
$17.13
VALE
+3.09%
$12.31
QS
+10.55%
$17.07
AAPL
+0.03%
$270.14
RIG
0.00%
$3.90
CAN
+16.21%
$1.29
U
+18.09%
$42.36
RGTI
+5.99%
$37.29
RMBL
+60.50%
$3.21
WULF
+2.33%
$15.36
FUBO
+10.86%
$4.08
AMZN
+0.35%
$250.20
ADD
-25.47%
$0.05
BURU
+0.20%
$0.29
NVO
+0.43%
$48.46
EPWK
-6.41%
$0.07
TLRY
+3.22%
$1.28
HIMS
+2.19%
$43.73
BTBT
+3.14%
$3.28
SRM
+53.27%
$10.30
NIO
+1.81%
$7.29
PCG
+0.68%
$16.27
BMNR
+4.96%
$41.42
NCLH
-0.95%
$18.61
ZDAI
+13.94%
$0.52
RIOT
-1.58%
$18.97
JOBY
+1.62%
$15.00
NOK
+0.58%
$6.85
HTZ
-0.81%
$6.67
APPS
+23.14%
$7.29
CMG
+0.72%
$31.97
ALIT
-7.03%
$2.50
QBTS
+4.30%
$31.02
NGD
+2.40%
$6.80
GOOGL
+2.43%
$284.31
HOOD
+4.15%
$142.47
BBD
+3.62%
$3.53
BW
+28.34%
$4.80
NVTS
-5.73%
$9.86
WLGS
-5.57%
$0.04
MU
+8.93%
$237.50
IONZ
-7.60%
$4.13
SOUN
+3.89%
$15.72
HPE
+0.63%
$23.71
AG
-7.69%
$10.67
RDHL
+2.77%
$1.11
PLTZ
+2.80%
$6.24
GGB
+5.26%
$3.60
ETWO
0.00%
$3.30
HBAN
+0.13%
$15.29
CPNG
-5.94%
$30.22
PBR
+2.62%
$12.14
ABEV
+1.25%
$2.42

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.